Clinical trial

Insulin Glulisine in Diabetes Mellitus, Type 2

NCT00174668

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2004-11-01

PhasePHASE3

Study timeline

Study start (unknown)2004-11-01Date precision: month

Registry last updated2009-09-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetes Mellitus, Type 2unresolved

Interventions

Insulin GlulisineDRUG · verified · RxNorm: insulin glulisine, human

Insulin TherapyDRUG

Insulin GlargineDRUG · verified · RxNorm: insulin glargine

Sponsors & collaborators

Sanofilead sponsor

Mapped research locations

BarcelonaSpain1 ParisFrance1 BerlinGermany1 MilanItaly1 WarsawPoland1 PragueCzechia1 BrusselsBelgium1 BucharestRomania1 StockholmSweden1 BratislavaSlovakia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00174668 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.